Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4471 to 4485 of 8314 results

  1. Dopamine: In people with acute heart failure, congestion and worsening renal function, does the addition of low‑dose dopamine to standard therapy lead to greater diuresis and renal protection compared with adding placebo to standard therapy?

    Recommendation ID CG187/01 Question Dopamine: In people with acute heart failure, congestion and worsening renal function, does the addition

    Research recommendation
    Published
    16 December 2021

  2. Diuretic therapy for managing fluid overload in people with advanced heart failure in the community:-  In people with advanced heart failure and significant peripheral fluid overload, what is the clinical and cost effectiveness of oral, subcutaneous and intravenous diuretic therapy in the community?

    Recommendation ID NG106/1 Question Diuretic therapy for managing fluid overload in people with advanced heart failure in the community:-

    Research recommendation
    Published
    17 December 2018

  3. Mucolytic therapy:- In people with COPD, does mucolytic drug therapy prevent exacerbations in comparison with placebo and other therapies?

    Recommendation ID NG115/11 Question Mucolytic therapy:- In people with COPD, does mucolytic drug therapy prevent exacerbations in comparison

    Research recommendation
    Published
    13 February 2019

  4. Ultrafiltration: In people with decompensated heart failure, fluid congestion and diuretic resistance, does ultrafiltration lead to more rapid and effective decongestion compared with continuing diuretic treatment?

    Recommendation ID CG187/04 Question Ultrafiltration: In people with decompensated heart failure, fluid congestion and diuretic resistance

    Research recommendation
    Published
    16 December 2021

  5. In people with high-risk non-muscle-invasive bladder cancer, are these follow-up regimens equally effective in terms of identification of progression, cost effectiveness and health-related quality of life? - Cystoscopic follow-up at 3, 6, 12, 18, 24, 36 and 48 months, and then annually, interspersed with non-invasive urinary tests. - Cystoscopic follow-up at 3, 6, 9, 12, 15, 18, 21, 24, 30, 36, 42 and 48 months, and then annually thereafter.

    Recommendation ID NG2/3 Question In people with high-risk non-muscle-invasive bladder cancer, are these follow-up regimens equally effective

    Research recommendation
    Published
    9 June 2015

  6. Vitamin D supplements in the management of CKD–mineral and bone disorders: In people with hyperparathyroidism secondary to CKD, does treatment with vitamin D or vitamin D analogues improve patient-related outcomes?

    Recommendation ID NG203/21 Question Vitamin D supplements in the management of CKD–mineral and bone disorders: In people with hyperparathyroidism

    Research recommendation
    Published
    30 September 2021

  7. Techniques for confirming a diagnosis in people with suspected atypical Spitzoid melanocytic lesions: In people with reported atypical Spitzoid lesions, how effective are fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH) and tests to detect driver mutations compared with histopathological examination alone in predicting disease specific survival? This should be investigated ina prospective diagnostic study. Secondary outcomes should include sensitivity, specificity, accuracy, positive predictive value, disease specific survival and progression free survival.

    Recommendation ID NG14/07 Question Techniques for confirming a diagnosis in people with suspected atypical Spitzoid melanocytic lesions:

    Research recommendation
    Published
    4 August 2022

  8. Vitamin D supplementation: In people with stage I to III melanoma does vitamin D supplementation improve overall survival? This should be investigated in a placebo controlled randomised trial. Secondary outcomes should include disease specific survival and toxicity, including the development of renal stones and hypercalcaemia.

    Recommendation ID NG14/09 Question Vitamin D supplementation: In people with stage I to III melanoma does vitamin D supplementation improve

    Research recommendation
    Published
    4 August 2022

  9. In people with suspected COVID-19-associated pulmonary aspergillosis (CAPA), what are the most accurate tests for diagnosing the infection and when should they be done?

    Recommendation ID NG191/12 Question In people with suspected COVID-19-associated pulmonary aspergillosis (CAPA), what are the most accurate

    Research recommendation
    Published
    17 December 2021

  10. Diagnostic criteria: In people with suspected ME/CFS, how effective is the NICE 2021 consensus-based diagnostic criteria in identifying people with ME/CFS?

    Recommendation ID NG206/03 Question Diagnostic criteria: In people with suspected ME/CFS, how effective is the NICE 2021 consensus-based

    Research recommendation
    Published
    8 November 2021

  11. Diagnosis of chronic pancreatitis:- In people with suspected (or under investigation for) chronic pancreatitis, whose diagnosis has not been confirmed by the use of 'first-line' tests (for example, CT scan, ultrasound scan, upper gastrointestinal [GI] endoscopy or combinations of these), what is the accuracy of magnetic resonance cholangiopancreatography (MRCP) with or without secretin and endoscopic ultrasound to identify whether chronic pancreatitis is present?

    Recommendation ID NG104/1 Question Diagnosis of chronic pancreatitis:- In people with suspected (or under investigation for) chronic pancreatitis

    Research recommendation
    Published
    17 December 2018

  12. Is an integrated care system effective at promoting successful progress for people with complex psychosis to a more independent setting?

    Recommendation ID NG181/6 Question Is an integrated care system effective at promoting successful progress for people with complex psychosis

    Research recommendation
    Published
    26 October 2020

  13. Intensity of home care packages:- What is the effectiveness and cost effectiveness of different intensities of home care packages for older people with a range of care and support needs?

    Recommendation ID NG21/1 Question Intensity of home care packages:- What is the effectiveness and cost effectiveness of different intensities

    Research recommendation
    Published
    13 October 2015

  14. What is the clinical and cost effectiveness of more intensive cognitive and psychological therapy compared to usual care for people after a stroke?

    Recommendation ID NG236/2 Question What is the clinical and cost effectiveness of more intensive cognitive and psychological therapy compared

    Research recommendation
    Published
    11 January 2024

  15. What is the clinical and cost effectiveness of delivering rehabilitation for 7 days a week compared to 5 days a week for people after a stroke?

    Recommendation ID NG236/1 Question What is the clinical and cost effectiveness of delivering rehabilitation for 7 days a week compared

    Research recommendation
    Published
    11 January 2024